Foundation of ITCC-P4 legal entity

The sustainable non-profit legal entity ITCC-P4 gGmbH was established under German Law in April 2023 to make ≈400 new patient-derived in vivo preclinical models of high-risk paediatric solid tumours and leukaemias available for preclinical drug testing both for industry and academic customers.

A press release addressing the foundation of ITCC-P4 legal entity can be found here.